Plegridy will be available on the NHS in Scotland

The Scottish Medicines Consortium (SMC) has approved peginterferon beta-1a (Plegridy) as a treatment for relapsing remitting multiple sclerosis on the NHS in Scotland.
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news